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Introduction: Changes to the U.S. smokeless tobacco landscape in recent years include a change to health
warnings on packages, the implementation of bans in some stadiums, and the launch of a federal youth prevention campaign. It is unclear whether such changes have impacted consumer beliefs about smokeless tobacco.
This study examines relative harm perceptions of smokeless tobacco compared to cigarettes among adults and
assesses changes in smokeless tobacco harm perceptions over time.
Methods: We analyzed data from three cycles (2012, 2014, 2015) of the Health Information National Trends
Survey (HINTS). Using 2015 data, we assessed bivariate associations between smokeless tobacco harm perceptions and tobacco use, beliefs, information seeking, and demographics. Using 2012, 2014, and 2015 data, we
assessed whether smokeless tobacco harm perceptions changed over time within demographic groups using chisquare tests. We then used a weighted multinomial logistic regression to assess the association between smokeless tobacco perceptions and survey year, adjusting for covariates.
Results: When asked whether smokeless tobacco products are less harmful than cigarettes, the majority of respondents across cycles said “no.” The percent of respondents who selected this response option decreased over
time. Findings showed signiﬁcant diﬀerences in relative harm perceptions of smokeless tobacco versus cigarettes
for speciﬁc demographic subgroups. Among subgroups, these shifts did not occur with a discernible pattern.
Conclusions: Understanding factors associated with perceptions of smokeless tobacco can inform tobacco control
eﬀorts. Additional monitoring of these trends may provide researchers with a deeper understanding of how and
why smokeless tobacco harm perceptions change.

1. Introduction
The U.S. smokeless tobacco landscape has changed in recent years.
From 2002-2012, self-reported cigarette use declined, while use of smokeless tobacco saw a slight but signiﬁcant increase (3.5% in 2002 to 3.7%
in 2012) (Agaku & Alpert, 2016). In 2009, the U.S. Food and Drug Administration (FDA) gained regulatory authority over the manufacture,

distribution and marketing of tobacco products, including smokeless tobacco products such as snuﬀ and chewing tobacco (Public Law 111-31,
2009). Eﬀective in 2010, Congress required manufacturers to display
larger warning messages on smokeless tobacco packages (U.S. Food and
Drug Administration, 2016), and in 2015, FDA authorized the marketing
of eight new smokeless tobacco products, under the premarket tobacco
application pathway, which requires FDA to consider the impact of
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reported thinking about the harms of smoking recently were likely to
believe smokeless tobacco was less harmful than smoking (O'Connor
et al., 2005).
The current study examined relative harm perceptions of smokeless
tobacco compared to traditional cigarettes in a nationally representative sample of U.S. adults, diﬀerences in perceptions by demographic characteristics and other factors (addiction beliefs, cancer
beliefs and information seeking behaviors), and whether the prevalence
of harm perceptions diﬀers across three time points among the overall
sample and subgroups. We looked at diﬀerences in perceptions by
subgroup because previous research has shown that harm perceptions
of smokeless tobacco diﬀer by demographic and tobacco use subgroups
(O'Connor et al., 2005). By increasing our understanding of the public's
perceptions about these products and how perceptions are have
changed in recent years, our ﬁndings may help inform public health
communications aimed at reducing tobacco-related harms. Additionally, understanding consumer perceptions of tobacco products
plays an important role in FDA's regulatory work. For example, FDA has
published draft guidance (U.S. Food and Drug Administration, n.d.)
explaining the usefulness of data on consumer perceptions of tobacco
products in informing FDA decision-making related to the marketing of
modiﬁed risk tobacco products which, when ﬁnalized, will represent
the agency's current thinking on this issue.

marketing new tobacco products on the population as a whole (Food and
Drug Administration, 2015). Several cities have recently banned smokeless
tobacco use in baseball stadiums (Municipal Code of Chicago, n.d.; Admin.
Code, n.d.; Mun. Code, n.d.; Los Angeles Municipal Code, n.d.). Additionally, in 2016, FDA launched the ﬁrst federal campaign aimed at
preventing smokeless tobacco use among youth living in rural areas (FDA,
2016). These changes have been accompanied by a debate among experts
regarding whether smokeless tobacco products oﬀer a “reduced harm”
alternative to cigarettes (Hatsukami, Lemmonds, & Tomar, 2004; Savitz,
Meyer, Tanzer, Mirvish, & Lewin, 2006). Some experts argue that smokeless tobacco use presents reduced health risks compared to cigarette use
and, therefore, smokeless tobacco use should be promoted as an alternative to cigarette, while others argue that smokeless tobacco still presents
health risks and, therefore, should not be promoted by public health ofﬁcials (Gartner, Hall, Chapman, & Freeman, 2007; Hatsukami et al., 2004).
The FDA has the authority to determine whether an individual product can
be marketed as a modiﬁed risk tobacco product based on data submitted
for the individual product. To make that determination, the FDA must use
a population health perceptive that considers the impact that such a determination would be likely to have, including “the increased or decreased
likelihood that existing users of tobacco products will stop using such
products” and “the increased or decreased likelihood that those who do
not use tobacco products will start using such products.” (US Congress,
n.d.). To date, FDA has not made a determination that any smokeless tobacco products are modiﬁed risk tobacco products. This question of reduced harm alternatives to cigarettes has intensiﬁed in recent years with
the introduction of e-cigarettes onto the market (Munz, 2016; Carroll,
2016; Hajek, Etter, Benowitz, Eissenberg, & McRobbie, 2014; Institute of
Medicine, 2001; Kozlowski, 2007, 2015; Zeller, 2013). It is unclear whether, in response to these marketing and regulatory changes, consumers
have altered their beliefs about harms of smokeless tobacco.
Behavioral theories posit that harm perceptions predict health-related
behaviors (Ajzen, 1985; Janz & Becker, 1984; Rosenstock, Strecher, & Becker,
1988) and, in the case of cigarette use, empirical evidence supports these
theories (Cengelli, O'Loughlin, Lauzon, & Cornuz, 2012; Wellman, Dugas,
Dutczak, et al., 2016). While research on the relationship between harm
perceptions and smokeless tobacco use is limited, evidence from three studies
suggests that the perception that smokeless tobacco use presents low risk is
associated with smokeless tobacco use (Gansky, Ellison, Kavanagh,
Isong, & Walsh, 2009; Kaufman, Mays, Koblitz, & Portnoy, 2014; Walsh,
Ellison, Hilton, Chesney, & Ernster, 2000) (consistent with ﬁndings on risk
perceptions among cigarette smokers (Slovic, 2001)). Additionally, research
suggests that cigarette smokers are interested in using “reduced harm” tobacco products (Berg, Haardoerfer, Escoﬀery, Zheng, & Kegler, 2015;
Parascandola, Augustson, O'Connell, & Marcus, 2009). Given the harms associated with smokeless tobacco use (U.S. Department of Health and Human
Services, 2014; World Health Organization International Agency for Research
on Cancer, 2007), it is important to further study smokeless tobacco perceptions.
Previous national surveys of U.S. adults, ﬁelded between 2002
(O'Connor, Hyland, Giovino, Fong, & Cummings, 2005) to 2013
(Kaufman et al., 2014; Kiviniemi & Kozlowski, 2015), have found that
less than a quarter of respondents believe smokeless tobacco is less
harmful than cigarettes (Kaufman et al., 2014; Kiviniemi & Kozlowski,
2015; O'Connor et al., 2005, 2007; Popova & Ling, 2013; Regan,
Dube, & Arrazola, 2012). To our knowledge, few national adult surveys
have assessed correlates of relative harm perceptions of smokeless tobacco compared to cigarettes. A 2013 survey found that adults who
perceived snus to be less harmful and addictive than cigarettes were
more likely to have used snus compared to respondents who believed
snus was at least as harmful and addictive as cigarettes (Kaufman et al.,
2014). A 2012-2013 survey of U.S. adults found no diﬀerences in relative harm perceptions of smokeless tobacco compared to cigarettes by
smoking status (Kiviniemi & Kozlowski, 2015). The 2003 International
Tobacco Control Policy Four-Country Survey, ﬁelded among U.S. adult
cigarette smokers, found that men, younger adults, and those who

2. Methods
2.1. Data
Data were drawn from three cycles of the Health Information
National Trends Survey (HINTS). HINTS is a nationally representative,
cross-sectional, mail-based survey of civilian, non-institutionalized
adults aged 18 +. HINTS data are publicly available (National Cancer
Institute, n.d.). We used data from HINTS 4 Cycle 2 collected October
2012-January 2013 with a 40% response rate (N = 3,630); HINTS 4
Cycle 4 data collected August-November 2014 with a 34% response rate
(N = 3,677); and the 2015 cycle, referred to as HINTS-FDA 2015,
collected May-September 2015 with a 33% response rate (N = 3,738).
Methods for HINTS-FDA 2015 are described elsewhere (Blake, Portnoy,
Kaufman, et al., in press). All cycles were approved by the Oﬃce of
Management and Budget and deemed exempt by the National Institute
of Health Oﬃce of Human Subjects Research.
2.2. Measures
All three HINTS cycles included harm perceptions and demographic
measures. Use of cigarettes, cigars, and smokeless tobacco; addiction
beliefs; and information seeking were only measured in 2015. While the
cancer belief construct was measured in all three cycles, the questions
used to measure this construct changed in 2015; thus, we included
cancer beliefs only in the analysis of 2015 data.
2.2.1. Harm perceptions
The primary dependent variable was relative harm perceptions of
smokeless tobacco use compared to cigarette smoking. Respondents
were asked, “In your opinion, do you think that some smokeless tobacco
products, such as chewing tobacco, snus and snuﬀ are less harmful to a
person's health than cigarettes?” Response options were “Yes,” “No,”
and “Don't know.”
2.2.2. Use of cigarettes, cigars, and smokeless tobacco
Respondents were asked if they had smoked at least 100 cigarettes
in their lifetime and if they now use cigarettes “Every day,” “Some
days,” or “Not at all.” Items assessed the number of cigars, cigarillos, or
little ﬁltered cigars smoked in the respondent's lifetime and current use.
Respondents were asked if they had used chewing tobacco, snus, snuﬀ,
or dip at least 20 times in their lifetime and if they currently use
8
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Table 1
Factors associated with the belief that smokeless tobacco use is less harmful than cigarettes: HINTS-FDA 2015.

Overall
Sex
Male
Female
Age (years)
18–34
35–49
50–64
65 +
Race/ethnicity
White, Not Hispanic
Black, Not Hispanic
Hispanic
Multiple races or other
Education
Less than high school
High school graduate
Vocational or some college
College graduate or postgraduate
Household income
< $35,000
$35,000 to $74,999
$75,000 or more
Current tobacco usea
Yes
No
Smokeless tobacco useb
Ever use
Never use
Residence typec
Urban county
Rural county
Census division
New England
Middle Atlantic
East North Central
West North Central
South Atlantic
East South Central
West South Central
Mountain
Paciﬁc
Census region
Northeast
Midwest
South
West
Addiction beliefs about smokeless tobaccod
Very addictive
Moderately addictive
Not at all addictive
Don't know
Information seekinge
Health eﬀects (% Yes)
Products that claim to reduce exposure to certain chemicals or
present less risk of disease (% Yes)
Quitting help/information (% Yes)
List of chemicals in tobacco products (% Yes)
Cost/Coupons (% Yes)
Instructions/tutorials
(% Yes)
Where to buy (% Yes)
Information about new kinds of tobacco products (% Yes)
Never looked for any of this information (% Yes)
Other
Cancer beliefsf
Person's behavior/lifestyle causes cancer
Strongly agree
Somewhat agree
Somewhat disagree
Strongly disagree

Overall n (weighted
%)

Yes, SLT less
harmful
Weighted % (95%
CI)

No, SLT not less
harmful
Weighted % (95%
CI)

Don't Know if SLT less
harmful
Weighted % (95% CI)

p-Value

3,738

10.9 (9.4, 12.8)

66.8 (63.9, 69.6)

22.2 (20.0, 24.7)

p = 0.001

1,497 (46.5)
2,018 (48.2)

13.7 (11.0, 16.8)
8.7 (6.8, 11.2)

65.3 (60.7, 69.5)
69.5 (65.9, 72.8)

21.1 (17.6, 25.1)
21.8 (18.9, 25.0)

p = 0.02

455 (29.5)
659 (24.3)
1,226 (24.9)
1,288 (18.4)

9.5 (5.7, 15.3)
13.4 (9.4, 18.8)
11.8 (9.7, 14.2)
10.0 (8.3, 12.1)

72.6
63.7
68.3
60.4

(65.4,
(58.5,
(64.4,
(56.6,

78.8)
68.7)
71.9)
64.0)

17.9
22.8
20.0
29.6

(12.4,
(18.2,
(16.6,
(26.2,

25.3)
28.2)
23.8)
33.2)

p = 0.06

2,633 (59.6)
232 (10.4)
517 (20.6)
312 (8.5)

10.5 (8.6, 12.9)
10.0g (4.4, 21.3)
11.4 (7.7, 16.6)
13.8 (8.4, 21.8)

73.5
63.0
53.2
57.9

(70.4,
(51.4,
(46.6,
(46.5,

76.4)
73.3)
59.6)
68.6)

15.9
26.9
35.4
28.3

(14.1,
(18.1,
(29.7,
(19.6,

17.9)
38.1)
41.5)
38.9)

p = 0.00

237 (10.7)
727 (20.7)
1,132 (32.3)
1,578 (34.7)

8.2g (4.1, 15.6)
9.0 (5.4, 14.5)
10.4 (7.2, 14.9)
13.8 (11.5, 16.4)

58.9
66.1
70.7
66.1

(48.2,
(57.9,
(64.9,
(61.9,

68.7)
73.4)
75.9)
70.1)

32.9
24.9
18.8
20.1

(23.9,
(19.4,
(14.9,
(16.5,

43.3)
31.4)
23.4)
24.2)

p = 0.04

1,170 (32.1)
1,020 (27.0)
1,112 (32.2)

10.5 (7.1, 15.2)
8.9 (6.9, 11.4)
13.2 (10.4, 16.6)

61.0 (55.3, 66.3)
73.0 (69.0, 76.6)
70.1 (64.9, 74.9)

28.5 (24.1, 33.4)
18.1 (14.7, 22.0)
16.7 (13.3, 20.7)

p = 0.0004

616 (18.2)
3,067 (80.6)

13.0 (9.4, 17.8)
10.6 (8.6, 12.9)

67.7 (62.6, 72.5)
66.6 (63.2, 69.8)

19.2 (14.4, 25.3)
22.8 (20.2, 25.7)

p = 0.37

327 (9.4)
3,347 (88.5)

23.6 (15.8, 33.6)
9.7 (8.0, 11.7)

68.6 (59.1, 76.7)
66.8 (63.7, 69.7)

7.8 (5.0, 12.0)
23.5 (21.1, 26.1)

p = 0.000

3,648 (98.3)
90 (1.7)

10.9 (9.2, 12.8)
13.9g (5.8, 30.0)

66.7 (63.7, 69.6)
72.6 (54.6, 85.4)

22.4 (20.0, 24.9)
13.4g (6.1, 26.9)

p = 0.38

163
444
783
322
708
316
367
242
393

6.4g (3.2, 12.3)
10.1 (7.1, 14.1)
9.0 (6.3, 12.7)
14.8 (9.5, 22.4)
12.8 (8.3, 19.2)
6.7 (4.2, 10.7)
9.4 (6.1, 14.1)
14.0g (6.5, 27.6)
12.1 (7.8, 18.2)

73.6
61.1
70.2
66.6
64.6
78.8
67.9
71.2
61.7

(59.1,
(54.1,
(63.8,
(54.9,
(58.7,
(70.7,
(59.6,
(59.8,
(52.8,

84.4)
67.7)
75.9)
76.5)
70.0)
85.2)
75.3)
80.4)
69.9)

19.9
28.8
20.8
18.6
22.6
14.4
22.6
14.8
26.2

(11.1, 33.1)
(23.1, 35.2)
(15.5, 27.3)
(9.9, 32.2)
(18.0, 27.9)
(8.9, 22.6)
(15.8, 31.3)
(9.6, 22.2)
(19.2, 34.6)

p = 0.18

607 (18.0)
1,105 (21.2)
1,391 (37.4)
635 (23.4)

8.9 (6.8, 11.8)
10.8 (8.4, 13.9)
10.9 (8.1, 14.5)
12.7 (8.7, 18.1)

64.9
69.1
67.8
64.6

(58.7,
(63.7,
(64.3,
(57.2,

70.7)
74.0)
71.2)
71.2)

26.1
20.1
21.3
22.8

(20.8,
(15.7,
(18.0,
(17.9,

p = 0.53

111 (40.5)
674 (20.1)
1,512 (4.3)
1,251 (30.1)

9.6 (7.6, 12.2)
18.7 (13.8, 24.8)
10.1 (5.6, 17.3)
7.4 (5.6, 9.7)

77.9
69.0
66.4
53.5

(72.9,
(62.2,
(48.8,
(49.1,

82.2)
75.1)
80.4)
57.9)

12.4 (9.0, 16.9)
12.3 (8.4, 17.6)
23.6g (10.7, 44.1)
39.0 (34.8, 43.5)

p = 0.000

648 (20.3)
175 (5.4)

12.9 (8.7, 13.0)
13.0 (7.5, 21.7)

67.0 (59.9, 73.4)
69.1 (55.8, 79.8)

20.1 (14.6, 26.9)
17.9 (9.6, 30.9)

p = 0.61
p = 0.73

458 (12.7)
281 (9.5)
321 (9.9)
37 (1.0)

15.4 (10.2, 22.5)
12.8 (7.9, 20.0)
12.1 (7.9, 17.9)
NAh

71.0 (62.8, 78.1)
76.5 (67.9, 83.4)
71.5 (63.0, 78.6)
NAh

13.6 (8.7, 20.7)
10.7 (6.4, 17.2)
16.5 (11.2, 23.6)
NAh

p = 0.03
p = 0.01
p = 0.38
p = 0.92

104 (2.9)
81 (2.5)
2,514 (64.4)
96 (2.6)

21.5g (11.2, 37.2)
16.5g (8.4, 29.7)
10.3 (8.2, 12.8)
6.8g (2.7, 16.0)

64.8
72.0
68.4
54.4

(49.9,
(55.5,
(64.7,
(35.7,

77.4)
81.2)
71.9)
71.9)

13.7
11.5
21.3
38.8

(7.9, 22.5)
(5.4, 22.7)
(18.4, 24.5)
(21.2, 59.8)

p = 0.04
p = 0.15
p = 0.49
p = 0.03

285 (9.3)
1,605 (40.5)
856 (23.0)
880 (24.9)

16.9 (10.7, 25.8)
11.0 (8.7, 13.9)
10.9 (7.3, 15.8)
8.9 (5.9, 13.2)

56.3
69.7
71.4
64.2

(45.9,
(65.2,
(65.3,
(58.3,

66.2)
73.7)
76.9)
69.8)

26.7
19.3
17.7
26.8

(18.5,
(15.8,
(14.6,
(21.9,

p = 0.02

(5.5)
(12.5)
(14.7)
(6.5)
(21.4)
(6.1)
(9.9)
(7.0)
(16.4)

32.1)
25.3)
24.9)
28.5)

36.9)
23.3)
21.2)
32.4)

(continued on next page)
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Table 1 (continued)

Everything causes cancer
Strongly agree
Somewhat agree
Somewhat disagree
Strongly disagree
Cancer prevention is not possible
Strongly agree
Somewhat agree
Somewhat disagree
Strongly disagree
Cancer prevention recommendations are hard to follow
Strongly agree
Somewhat agree
Somewhat disagree
Strongly disagree

Overall n (weighted
%)

Yes, SLT less
harmful
Weighted % (95%
CI)

No, SLT not less
harmful
Weighted % (95%
CI)

Don't Know if SLT less
harmful
Weighted % (95% CI)

p-Value

582 (16.6)
1,406 (37.4)
849 (22.4)
767 (20.3)

10.5
10.7
10.0
13.4

70.9
70.7
69.0
57.4

(63.2,
(66.4,
(63.1,
(50.6,

77.5)
74.7)
74.3)
63.9)

18.6
18.5
21.0
29.2

(13.4,
(15.7,
(16.0,
(23.2,

25.3)
21.7)
27.1)
36.0)

p = 0.03

211 (7.3)
689 (18.4)
1,497 (41.0)
1,217 (30.4)

15.7g (6.3, 33.9)
8.4 (6.1, 11.6)
9.6 (7.5, 12.1)
13.5 (10.2, 17.7)

52.2
66.6
70.1
68.1

(39.7,
(60.0,
(65.5,
(64.6,

64.5)
72.6)
74.4)
70.2)

32.1
24.9
20.3
18.4

(19.9,
(19.3,
(19.9,
(19.3,

47.3)
31.6)
24.2)
23.9)

p = 0.06

1,191 (31.3)
1,619 (42.4)
526 (14.8)
308 (9.5)

9.1 (6.8, 12.1)
11.7 (9.3, 14.7)
10.8 (8.2, 13.9)
13.9g (6.8, 26.2)

68.6
66.6
69.1
61.2

(63.8,
(63.0,
(61.5,
(46.7,

73.0)
70.1)
75.8)
73.9)

22.2
21.6
20.1
24.9

(18.7,
(18.8,
(14.8,
(16.4,

26.3)
24.8)
26.7)
35.9)

p = 0.66

(6.8,
(8.3,
(7.8,
(8.6,

15.6)
13.8)
12.8)
20.2)

Boldface indicates statistical signiﬁcance (p < 0.05).
Abbreviations: CI – conﬁdence interval.
a
Current tobacco use is deﬁned as smoking at least 100 cigarettes, 50 cigars, or use of 20 smokeless products in a lifetime and now using cigarettes, cigars, and/or smokeless products
some or every day.
b
Ever use of smokeless tobacco is deﬁned as using chewing tobacco, snus, snuﬀ, or dip at least 20 times in a lifetime.
c
An urban county was a county in a metro area or a non-metro county with a population size greater than 2,500. A rural county is a non-metro county that is completely rural or less
than 2,500 in population size.
d
Respondents were asked about how addictive they believed smokeless tobacco use is with response options as follows: “Not at all addictive,” Moderately addictive,” “Very addictive,”
and “Don't know.”
e
Information seeking was assessed by asking respondents “Have you ever looked for any of the following information about tobacco products (e.g. cigarettes, cigars, or chewing
tobacco) from any source?” Respondents were able to select all response options that applied. The proportion responding “Yes” to each of the response options is presented.
f
Respondents were asked how much they agree or disagree with four statements regarding their cancer beliefs including: (1)“Cancer is most often caused by a person's behavior or
lifestyle;” (2)“It seems like everything causes cancer;” (3) “There's not much you can do to lower your chances of getting cancer;” (4) “There are so many diﬀerent recommendations about
preventing cancer, it's hard to know which ones to follow.
g
Estimates are ﬂagged because the relative standard error is greater than 30%.
h
Estimates are suppressed because the denominator is less than 50.

“Strongly Agree,” “Somewhat Agree,” “Somewhat Disagree,” “Strongly
Disagree.”

smokeless products. Current use of a tobacco product was deﬁned as
having used at least 100 cigarettes, 50 or more cigars, or 20 smokeless
tobacco products in a lifetime and currently using cigarettes, cigars,
and/or smokeless tobacco products some days or every day, consistent
with previous research (Hu, Neﬀ, Agaku, et al., 2016). We deﬁned ever
smokeless tobacco use as respondents who had used chewing tobacco,
snus, snuﬀ, or dip at least 20 times in their lifetime.

2.2.6. Demographic variables
Our analysis included: rural/urban residence, gender, education,
annual household income, and race/ethnicity. Rural/urban residence
was categorized based on respondent address for census region, division, and residence in an urban or rural area. Urban/rural county residence was based on the 2003 US Department of Agriculture's rural/
urban designation (USDA Economic Research Service, n.d.). Urban
counties were counties in metro areas or non-metro counties with population sizes greater than 2,500. Rural counties were non-metro
counties that were completely rural or less than 2,500 in population
size.

2.2.3. Addiction beliefs
Respondents were asked: “How addictive do you believe the following is: smokeless tobacco use.” Response options were “Not at all
addictive,” “Moderately addictive,” “Very addictive,” and “Don't
know.”
2.2.4. Information seeking
Respondents were asked: “Have you ever looked for any of the
following information about tobacco products (i.e., cigarettes, cigars, or
chewing tobacco) from any source?” Respondents could select all applicable responses: health eﬀects, products that claim to reduce exposure to certain chemicals or present less risk of disease, quitting help/
information, list of chemicals in tobacco products, cost/coupons, instructions/tutorials, where to buy, information about new kinds of tobacco products, something else.

2.3. Statistical Analysis
Data were analyzed in 2016. Stata 14 with survey procedures was
used for this analysis (StataCorp, 2015). To account for the complex
sampling design and to generate nationally representative estimates at
each time point, all analyses incorporated jackknife replicate weights.
With 2015 data, we conducted chi-square tests to examine bivariate
associations between smokeless tobacco harm perceptions and tobacco
use, beliefs, information seeking and demographic characteristics. With
2012, 2014, and 2015 data, we conducted chi-square tests to assess
whether smokeless tobacco harm perceptions changed over time within
each demographic subgroup. Using 2012, 2014, and 2015 data, we used
a weighted multinomial logistic regression to examine the association
between smokeless tobacco harm perceptions and survey year, adjusting for demographic variables including gender, age, race/ethnicity,
household income, education, and rural/urban residence. Respondents
selecting “no” (smokeless tobacco is not less harmful than cigarettes)

2.2.5. Cancer beliefs
Respondents were given four statements: (Agaku & Alpert, 2016)
“Cancer is most often caused by a person's behavior or lifestyle;” (Public
Law 111-31, 2009) “It seems like everything causes cancer;” (U.S. Food
and Drug Administration, 2016) “There's not much you can do to lower
your chances of getting cancer;” (Food and Drug Administration, 2015)
“There are so many diﬀerent recommendations about preventing
cancer, it's hard to know which ones to follow.” Response options were:
10
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demographic characteristics. The odds of believing that smokeless tobacco is less harmful than cigarettes, compared to not holding that
belief, was signiﬁcantly lower for women versus men (OR = 0.74, 95%
CI = 0.58, 0.95). Compared to non-Hispanic White adults, other racial/
ethnic subgroups had more than two times the odds of reporting “don't
know” versus “no” when asked whether some smokeless tobacco products are less harmful than cigarettes (OR = 2.72, 95% CI = 2.12,
3.48) for Hispanics; OR = 2.75, 95% CI = 1.85, 4.08) for other racial/
ethnic groups). Those with higher household incomes were signiﬁcantly
less likely to report “don't know” versus “no,” compared to those with
an annual household income of less than $35,000 (OR$35,00095% CI = 0.55, 0.91; OR$75,000 + = 0.72, 95%
$74,999 = 0.71,
CI = 0.53, 0.97).

were the reference group. We estimated odds ratios for 1) respondents
reporting “yes” (smokeless tobacco is less harmful than cigarettes)
versus “no,” and 2) respondents reporting “don't know” versus “no.”
Estimates with denominators less than 50 were suppressed and those
with a relative standard error greater than 30% were noted, as they may
be unreliable and should be interpreted with caution.
3. Results
Weighted proportions of the relative harm perceptions of smokeless
tobacco compared to cigarettes in 2015, by demographic, tobacco use
and belief characteristics are displayed in Table 1. When asked whether
some smokeless tobacco products “are less harmful to a person's health
than cigarettes,” the majority of respondents (66.8%, 95% CI = 63.9,
69.6) said “no,” 22.2% (95% CI = 20.0, 24.7) said “don't know,” and
10.9% (95% CI = 9.4, 12.8) said “yes.” Chi-squared tests revealed
signiﬁcant diﬀerences in harm perceptions by gender, race/ethnicity,
education, household income, smokeless tobacco use, addiction beliefs,
certain information seeking behaviors, and certain cancer beliefs. In
general, male gender, higher education or income, and tobacco use was
associated with a greater likelihood of believing that SLT is less harmful
than cigarettes. Regarding cancer beliefs, the belief everything causes
cancer was signiﬁcantly associated with relative smokeless tobacco
harm perceptions, as was the belief that cancer is most often caused by
a person's behavior or lifestyle. However, the pattern was unclear for
the belief that cancer prevention is not possible and the belief that
cancer prevention recommendations are hard to follow. Regarding information seeking behaviors, signiﬁcant diﬀerences in harm perceptions were observed for respondents reporting that they had ever looked
for information about quitting help/information, chemicals in tobacco
products, and where to buy tobacco products.
Table 2 presents changes in relative harm perceptions of smokeless
tobacco compared to cigarettes in 2012, 2014 and 2015. Across the
cycles, the majority of respondents believed that smokeless tobacco was
not less harmful than cigarettes. There were signiﬁcant diﬀerences in
relative harm perceptions of smokeless tobacco compared to cigarettes
across cycles for the overall population (p = 0.0001). The percent of
respondents who did not believe smokeless tobacco was less harmful
than cigarettes decreased over time (73.5% in 2012, 72.1% in 2014,
and 66.8% in 2015).
While we observed signiﬁcant diﬀerences in smokeless tobacco
harm perceptions across cycles for demographic subgroups (Table 2),
we did not observe an overarching consistent pattern in how these
perceptions changed. For instance, the belief that some smokeless tobacco products were less harmful than cigarettes was higher for women
in 2015 compared to 2012, but the percent of women endorsing this
belief peaked in 2014. Similar non-linear patterns were seen for respondents who were older (ages 50–64 years and 65+ years); nonHispanic Black adults; those with low income (< $35,000); and those
living in non-rural counties. Other subgroups exhibited diﬀerent patterns in relative harm perceptions across cycles. For example, the percent of 35–39 year-olds who believed some SLT products were less
harmful than cigarettes was lowest in 2014, while the percent of males
and college graduates reporting this belief increased from 2012 to
2014, and from 2014 to 2015. Of note, respondents answering “don't
know” to the harm perceptions question ﬂuctuated across cycles for
several subgroups. For example, the percent of men responding “don't
know” to this question was 17.0% (95% CI = 13.5, 21.3) in 2012,
14.1% (95% CI = 11.3, 17.5) in 2014, and 21.1% (95% CI = 17.6,
25.0) in 2015.
Table 3 presents changes in harm perceptions of smokeless tobacco
compared to cigarettes over time, controlling for demographic covariates. When asked whether some smokeless tobacco products are less
harmful than cigarettes, the odds of saying “don't know” versus “no”
was signiﬁcantly higher in 2015 compared to 2012 (OR = 1.41, 95%
CI = 1.08, 1.84). There were also signiﬁcant diﬀerences by

4. Discussion
We examined factors associated with relative harm perceptions of
smokeless tobacco compared to cigarettes. Across the three HINTS cycles, a majority of respondents reported that they did not think some
smokeless tobacco products were less harmful than cigarettes. The
percent of respondents with this belief decreased over time. After
controlling for demographic covariates, relative harm perceptions of
smokeless tobacco signiﬁcantly changed between 2012 and 2015 for
the US population and within demographic subgroups.
While we did not observe overarching patterns of change that were
consistent among the full population or speciﬁc subgroups over time,
our ﬁndings elucidate the complexity of understanding relative harm
perceptions of smokeless tobacco. For example, we explored factors that
we believed might be associated with smokeless tobacco harm perceptions from a theoretical perspective, such as cancer beliefs and information seeking behaviors. Results from the bivariate analyses
seemed to show inconsistent results, whereby the belief everything
causes cancer was signiﬁcantly associated with the outcome of interest,
but the belief that cancer prevention is not possible showed no signiﬁcant association. These two constructs may not be as closely related
as they appear to be. Additionally, certain information seeking behaviors were signiﬁcantly associated with relative harm perceptions of
smokeless tobacco, while others were not; there did not seem to be
common characteristics between signiﬁcant versus non-signiﬁcant behaviors. It could be that these constructs are not associated with smokeless tobacco harm perceptions or that this survey did not adequately
measure those constructs.
It is unclear why consumers maintain or change their smokeless
tobacco harm perceptions over time. Possibly, as more products are
introduced onto the marketplace, such as e-cigarettes, consumers are
prompted to reconsider their perceptions of existing products. It is also
possible that, in this new environment in which conﬂicting messages
about the harms of e-cigarettes are communicated in media (Tavernise,
n.d.; Wall Street Journal, n.d.; Clarke, n.d.), answering questions about
tobacco-related harms may require respondents to exert more cognitive
eﬀort than it previously did. This may explain the shift seen (Krosnick,
1991), whereby the percent of respondents answering “don't know” to
the relative harm perception question increased over time. Similar to
previous research, our analysis found that being non-White was associated with selecting “don't know” in response to the risk perception
question (Waters, Hay, Orom, Kiviniemi, & Drake, 2013). We were unable to identify another question with a “don't know” response that was
asked in all three HINTS survey years (2012, 2014, and 2015). Thus, we
cannot know whether “don't know” responses would have increased for
other questions over time, or whether this phenomenon is unique to the
harm perceptions question. Variations in the amount of tobacco advertising to which consumers have been exposed around the time surveys were ﬁelded could also explain changes in smokeless tobacco
perceptions across cycles. E-cigarette advertising has increased in recent years (Cantrell, Emelle, Ganz, Hair, & Vallone, 2016; Kim,
Arnold, & Makarenko, 2014; Kornﬁeld, Huang, Vera, & Emery, 2015);
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0.03
0.01
0.0001

0.04
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p-Valuea

Boldface indicates statistical signiﬁcance (p < 0.05).
Abbreviations: CI – conﬁdence interval.
a
A p-value less than 0.05 indicates a statistically signiﬁcant diﬀerence between smokeless tobacco use harm perceptions between years within each demographic group, estimated based on a χ2 test of association weighted for the survey design.
b
An urban county was a county in a metro area or a non-metro county with a population size greater than 2,500. A rural county is a non-metro county that is completely rural or less than 2,500 in population size.
c
Estimates are ﬂagged because the relative standard error is greater than 30%.

High school graduate
Vocational or some
college
College graduate or
postgraduate
Household income
< $35,000
$35,000 to $74,999
$75,000 or more
Residence typeb
Urban county
Rural county

Overall
Gender
Male
Female
Age (years)
18–34
35–49
50–64
65 +
Race/ethnicity
White, Not Hispanic
Black, Not Hispanic
Hispanic
Multiple races or other
Educatio
Less than high school

Yes, SLT less
harmful
Weighted %
(95% CI)

2012

Table 2
Changes in the Perception that Smokeless Tobacco use is less harmful than cigarettes by Demographic Covariates: HINTS 2012, 2014, 2015.
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Table 3
Factors associated with changes in harm perceptions of smokeless tobacco between 2012, 2014 and 2015, controlling for demographic characteristics.
p-Value

Yes (vs No)a
OR (95% CI)
Survey year
2012
2014
2015
Gender
Male
Female
Age (years)
18–34
35–49
50–64
65 +
Race/ethnicity
White, Not Hispanic
Black, Not Hispanic
Hispanic
Multiple races or other
Education
Less than high school
High school graduate
Vocational or some college
College graduate or postgraduate
Household income
< $35,000
$35,000 to $74,999
$75,000 or more
Residence typeb
Urban county
Rural county

Don't Know (vs No)a
OR (95% CI)

p-Value

Ref.
1.24 (0.91, 1.71)
1.31 (0.96, 1.78)

0.17
0.09

Ref.
0.95 (0.74, 1.22)
1.41 (1.08, 1.84)

0.70
0.01

Ref.
0.74 (0.58, 0.95)

0.02

Ref.
0.97 (0.80, 1.17)

0.74

Ref.
1.41 (0.96, 2.05)
1.19 (0.83, 1.70)
1.18 (0.83, 1.67)

0.08
0.34
0.37

Ref.
1.49 (1.08, 2.06)
1.33 (0.96, 1.83)
2.15 (1.58, 2.92)

0.02
0.08
0.000

Ref.
1.43 (0.90, 2.27)
1.53 (1.05, 2.23)
1.54 (0.99, 2.40)

0.12
0.03
0.06

Ref.
2.75 (1.97, 3.82)
2.72 (2.13, 3.48)
2.75 (1.85, 4.08)

0.000
0.000
0.000

Ref.
0.68 (0.41, 1.26)c
0.77 (0.45, 1.30)c
0.85 (0.51, 1.43)c

0.13
0.32
0.55

Ref.
1.02 (0.68, 1.51)
0.91 (0.64, 1.29)
1.02 (0.69, 1.53)

0.92
0.59
0.91

Ref.
0.85 (0.61, 1.19)
0.94 (0.64, 1.38)

0.35
0.75

Ref.
0.71 (0.55, 0.91)
0.72 (0.53, 0.97)

0.01
0.03

Ref.
0.95 (0.45, 2.00)c

0.89

Ref.
0.75 (0.37, 1.51)c

0.42

Boldface indicates statistical signiﬁcance (p < 0.05).
a
Respondents were asked the following item to assess harm perceptions of smokeless tobacco products relative to cigarettes: “In your opinion, do you think that some smokeless
tobacco products, such as chewing tobacco, snus and snuﬀ are less harmful to a person's health than cigarettes?” Response options were “Yes,” “No,” and “Don't know.” In the multinomial
logistic regression model presented, “No” (SLT is not less harmful than cigarettes) served as the reference category compared to “Yes” (SLT is less harmful than cigarettes) and “Don't
know” (whether SLT is less harmful than cigarettes).
b
An urban county was a county in a metro area or a non-metro county with a population size greater than 2,500. A rural county is a non-metro county that is completely rural or less
than 2,500 in population size.
c
Estimates are ﬂagged because the relative standard error is greater than30%.

Third, we did not examine absolute harm perceptions of smokeless
tobacco because the question assessing this construct was inconsistent
across cycles. Ideally, we would have liked to assess both relative and
absolute harm perceptions. There were also other questions of interest
in 2015 that were not asked in 2012 or 2014. For example, had the
question assessing addiction beliefs been asked in multiple cycles, we
would have examined responses to the question over time. Smokeless
tobacco use was also only measured in 2015; we could not adjust for
changes in use over time. This is a limitation because diﬀerences in
smokeless tobacco use status could have helped explain some of the
changes in smokeless tobacco harm perceptions seen over time.
Understanding factors associated with relative harm perceptions of
smokeless tobacco versus cigarettes –in recent surveys and over time –
can inform tobacco regulatory and prevention eﬀorts. Our ﬁndings may
inform the development of tailored educational content for speciﬁc
subgroups. To build upon this study, future research might examine
absolute harm perceptions of smokeless tobacco and continue to track
changes in relative harm perceptions of smokeless tobacco. Research
examining which speciﬁc beliefs (e.g. beliefs about cancer or, beliefs
about addiction) drive harm perceptions of smokeless tobacco might
provide us with a more nuanced understanding of how consumers judge
smokeless tobacco products. In addition, focus groups may also provide
a deeper understanding of shifts over time in smokeless tobacco harm
perceptions.

tobacco industry spending on cigarette advertising/promotion decreased from 2012-2013 (Federal Trade Commission, 2016a); and
smokeless tobacco spending increased (Federal Trade Commission,
2016b). The type of tobacco advertising to which consumers are exposed may also inﬂuence perceptions (Wackowski, Lewis, & Delnevo,
2016); research indicates that tobacco industry marketing, framing ecigarettes and hookah as safe, appear to be eﬀective (Berg, Stratton,
Schauer, et al., 2015). The extent to which consumers are aware of the
harm reduction debates among experts – and the extent to which
awareness of such debates impacts consumer harm perceptions – is
unclear.
A strength of this study is its nationally representative sample. Also,
while previous studies have examined harm perceptions of smokeless
tobacco with cross-sectional data from one time point (Gansky et al.,
2009; Kaufman et al., 2014; Walsh et al., 2000), this study examines
how smokeless tobacco harm perceptions have changed over time.
This study was subject to several limitations. First, we examined
cross-sectional data. Longitudinal data may have provided deeper insight into reasons for diﬀerences in smokeless tobacco harm perceptions
since 2012. Nevertheless, examining responses to the same question
assessing smokeless tobacco harm perceptions across three cycles provides a unique snapshot of overarching changes in consumer perceptions over time and is a strength of this study. Second, estimates for
certain subpopulations of interest were unstable, which precludes us
from making inferences regarding their harm perceptions of smokeless
tobacco. For example, most ﬁndings for individuals living in rural areas,
who have a high prevalence of smokeless tobacco use, were unstable
(Rodu & Cole, 2009; Vander Weg, Cunningham, Howren, & Cai, 2011).

5. Conclusions
We observed signiﬁcant shifts in relative harm perceptions of
13
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